Lessons from Othman Laraki, CEO of Color Health, on Removing Friction for Virtual-first, End-to-end Cancer Care
Welcome back to the Pear Healthcare Playbook! Every week, we’ll be getting to know trailblazing healthcare leaders and diving into building a digital health business from 0 to 1.
We would greatly appreciate it if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests’ insights reach a larger audience!
Today we’re thrilled to get to know Othman Laraki, CEO of Color Health. Color Health offers a platform that delivers comprehensive, end-to-end care for patients with cancer with its 50-state medical practice. By combining genomics, telehealth, and logistics infrastructure, Color makes prevention, early detection, treatment and survivorship more accessible and proactive, bringing coordinated support directly to patients and their care teams.
In this episode, we explore how Color Health is reinventing cancer care through its virtual first model, why reducing friction in healthcare is so important for access, and how Color’s platform works across the entire cancer patient journey. We also discuss the company’s apt evolution over the past decade, Color’s collaborations with OpenAI and Google Cloud, and Othman’s vision for how AI can expand and enable high-quality cancer care.
If you prefer to listen:
Beginnings in the early days of tech
Othman’s roots trace back to Stanford in the late 1990s, right in the middle of the dot-com boom, where he was exposed early to the excitement of technology as a computer science major. He was involved in the Business Association of Stanford Entrepreneurial Students (BASES), which became his first entry point into entrepreneurship.
After a brief stint on the East Coast pursuing his MBA at MIT, Othman returned to the Bay Area. Through his time at Stanford, he had met Larry Page, Sergey Brin, and many other early members of Google. He eventually joined Google and was part of the team during the early development of the Chrome browser.
In 2008, he left Google and founded Mixer Labs, which built GeoAPI—a location engine that provided location data and tools for adding geolocation features to applications. Mixer Labs became one of Twitter’s earliest acquisitions in 2009, and Othman subsequently joined Twitter, where he led a significant portion of the company’s product organization.
Starting Color Health
Although moving from Twitter into healthcare might seem like a major shift, for Othman the transition was deeply personal. Both his grandmother and mother had been diagnosed with breast cancer and were carriers of the BRCA2 gene. That family history had made the connection between cancer and genetics very real long before he ever considered founding a healthcare company.
The founding team, composed of Elad Gil, Nish Bhat, Taylor Sittler, and Othman, entered healthcare largely as newcomers. What they did know was that the intersection of science, software, and biology was critical. If they could deliver a great experience at that intersection at a fraction of the cost of existing genetic testing, they believed they could build something transformative.
Looking back, they were right about the technology. Color still runs some of the best population-scale genetic testing in the world, including the NIH’s All of Us research program, one of the largest genomic datasets ever assembled. But they soon realized that the science was not the hardest part. Healthcare, they discovered, does not operate like consumer tech, where you can simply launch a product online and watch users adopt it.
Though Color began as a science-oriented company, as they progressively unpacked the market, they realized that success required a significant sales force and that the challenge was not happening at the individual test level. While new diagnostics or therapeutics often generate excitement as “breakthroughs,” the issue with diseases like cancer is fundamentally a systems-level challenge. For example, if someone claimed they had a technology that could reduce lung cancer mortality more than any drug in history, and was already covered by insurance, affordable, and recommended by guidelines, most would be astonished. But this already exists: annual low-dose CT for people with substantial smoking histories. Yet compliance rates today remain in the single digits. For Color, the mission became: How do we solve problems at the system level? A daunting task in an industry often considered immune to progress.
Creating a frictionless experience
While Othman was at Google, he worked on a product called Google Toolbar, a search box embedded directly into a user’s browser, allowing users to easily search without going to google.com. Very quickly, it became clear this was a huge unlock for the company with almost half of all Google searches coming from the browser-embedded toolbar. Initially, the team assumed that this product would help by simply increasing Google’s market share by making users more likely to choose Google over competitors like Bing. Instead, something more interesting happened–it made users search more. The product did not just capture existing demand, it expanded the total amount of searching people were doing. A simple reduction in friction substantively grew the TAM of search.
That insight followed Othman into healthcare. In the same way Amazon introduced one-click checkout, Color wanted to create that kind of experience for cancer screening. With colon cancer as an example, instead of waiting for a patient to remember to ask their PCP at age 45, Color can proactively reach out, surface personalized screening options based on location and insurance, and help them schedule with almost no effort. If and when a screening turns up a finding, Color does not just hand off a referral and hope it sticks. They automatically order the follow-up diagnostic, coordinate the prep work, and activate the virtual clinic. By eliminating drop-off at every serialized step, the entire care pathway becomes faster, smoother, and ultimately leads to better outcomes.
How AI has and will continue to play in Color
Over the past 2 years, Color has accelerated its AI strategy across the cancer care continuum. In June 2024, Color launched Cancer Copilot in collaboration with OpenAI, an assistant that helps clinicians to generate workups and treatment plans.
In October 2025, Color announced Color Assistant in collaboration with Google Cloud, deploying agents that can automate breast cancer screening from eligibility determination to appointment coordination. Any woman in the US who meets guidelines can interact with an agent and be directly routed to Color’s clinical team for referrals and follow-up care. This pilot program aims to reach 20-30,000 women as a social good initiative jointly funded by COlor and Google. As Othman notes, something of this scale would not have been possible without automation to make internal costs manageable.
Looking toward the future, Othman sees AI as a technological wave that will touch every corner of healthcare. But unlike much of today’s AI activity, which focuses on productivity gains or revenue optimization, he believes the true constraint in healthcare is access. Clinical reasoning is the connective tissue that links diagnostics, treatments, and procedures, and today society is under-supplied on clinical expertise by orders of magnitude. Othman imagines a future where every cancer patient has access to the equivalent of a world-class multidisciplinary team continuously analyzing their case—something only possible with AI systems working alongside clinicians.
Lessons from the tech playbook
Coming from a tech background, Othman brought several lessons into healthcare and had to learn a few new ones along the way.
Increase your “clock speed” — time is your scarcest resource
One of a startup’s most valuable resources is time. And in healthcare, whether for better or for worse, the ecosystem moves at a glacial pace. Othman emphasizes that founders must figure out ways to accelerate their own learning cycles independent of the external timelines of their domain. For example, regulatory changes, payer decisions, and procurement operate on the timescale of months and years–a timeline that can easily outlast a startup’s runway. Thus, winning companies are the ones who find paths, whether through product scope or go-to-market design that allow them to move and experiment quickly, so that market truths can be uncovered.
Approach the field with deep humility and scientific rigor
Healthcare is an industry where the systems are particularly complex, the stakes are high, and the practitioners carry decades of accumulated, nuanced knowledge. Othman stresses the importance of engaging deeply with scientists and clinicians, not just as a checkbox, but as a core part of the business’s offerings. Color’s early partnerships with world-class geneticists was not performative, but helped to ground the company’s approach in the realities of testing and patient care.
Master the go-to-market realities of a non-free market
Founders must invest just as much creativity into distribution as they put into designing their products. Unlike consumer tech, healthcare is not an open or efficient market. It is one that is shaped by misaligned incentives and gatekeepers are every single level. Many great technical products have failed not necessarily because the solution was wrong, but the business model of market access strategy was fundamentally mismatched with the way the industry functions. Having a substantive and nuanced understanding of payer incentives, regulatory constraints, workflows, and decision makers is a key differentiator with those who succeed and those who don’t.
Color Health is redefining how cancer care is delivered, making it proactive, coordinated, and accessible from the very first screening through diagnosis and treatment. It is a model built for the speed patients deserve and the clinical rigor the field demands.
Interested in Color Health? Learn more on their website, X, and LinkedIn .
 | A guest post by
|